Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Marinus Pharma CS (MRNS)

Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Marinus Pharmaceuticals: Q3 Earnings Snapshot AP - Tue Nov 12, 3:04PM CST

Marinus Pharmaceuticals: Q3 Earnings Snapshot

MRNS : 0.3248 (+0.93%)
Author
3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity MarketBeat - Fri Oct 11, 8:28AM CDT

Check out these three micro-cap stocks that show big-time potential upside, but also pose face large obstacles to achieving success.

IWC : 137.42 (+0.42%)
LODE : 0.3570 (-0.83%)
AMPX : 1.9600 (-1.01%)
SPY : 598.83 (-0.30%)
MRNS : 0.3248 (+0.93%)
Author
Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech? MarketBeat - Tue Oct 1, 9:48AM CDT

Marinus is an under $2 biotech stock with Wall Street analysts price targets ranging from $2 to $13. Its upcoming trial results have big implications.

MRNS : 0.3248 (+0.93%)
Marinus Pharmaceuticals: Q2 Earnings Snapshot AP - Tue Aug 13, 6:07AM CDT

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 0.3248 (+0.93%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 8, 6:29AM CDT

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 0.3248 (+0.93%)
Marinus Pharmaceuticals: Q4 Earnings Snapshot AP - Tue Mar 5, 3:24PM CST

Marinus Pharmaceuticals: Q4 Earnings Snapshot

MRNS : 0.3248 (+0.93%)
Marinus Pharmaceuticals: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Marinus Pharmaceuticals: Q3 Earnings Snapshot

MRNS : 0.3248 (+0.93%)
Marinus Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 0.3248 (+0.93%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot AP - Thu May 11, 2023

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 0.3248 (+0.93%)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - Wed May 3, 2023

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present...

MRNS : 0.3248 (+0.93%)

Barchart Exclusives

Buy the Dip in This Dividend Aristocrat for a Strong 2025 Barchart - 52 minutes ago
McDonald's has faced challenges in 2024, including an E. coli outbreak, but is investing $100 million to recover and win back customers. With a strong brand, solid finances, and a clear growth strategy, the company's recent dip presents a rare chance to invest in a proven market leader with a long-term dividend growth streak. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot